ST elevation myocardial infarction discharge care: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
/* Implantable Cardioverter-Defibrillator Therapy Before Discharge (DO NOT EDIT){{cite journal |author=O'Gara PT, Kushner FG, Ascheim DD, et al. |title=2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Sum... |
||
| Line 7: | Line 7: | ||
===Implantable Cardioverter-Defibrillator Therapy Before Discharge (DO NOT EDIT)<ref name="pmid23247303">{{cite journal |author=O'Gara PT, Kushner FG, Ascheim DD, ''et al.'' |title=2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines |journal=Circulation |volume= |issue= |pages= |year=2012 |month=December |pmid=23247303 |doi=10.1161/CIR.0b013e3182742c84|url=}}</ref>=== | ===Implantable Cardioverter-Defibrillator Therapy Before Discharge (DO NOT EDIT)<ref name="pmid23247303">{{cite journal |author=O'Gara PT, Kushner FG, Ascheim DD, ''et al.'' |title=2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines |journal=Circulation |volume= |issue= |pages= |year=2012 |month=December |pmid=23247303 |doi=10.1161/CIR.0b013e3182742c84|url=}}</ref>=== | ||
{|class="wikitable" | |||
|- | |||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Implantable cardioverter-defibrillator therapy is indicated before discharge in patients who develop sustained ventricular tachycardia/ventricular fibrillation more than 48 hours after STEMI, provided the arrhythmia is not due to transient or reversible ischemia, reinfarction, or metabolic abnormalities.<ref name="pmid7697849">{{cite journal |author=Wever EF, Hauer RN, van Capelle FL, ''et al.'' |title=Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors |journal=Circulation |volume=91 |issue=8 |pages=2195–203 |year=1995 |month=April |pmid=7697849 |doi= |url=}}</ref><ref name="pmid8160593">{{cite journal |author=Siebels J, Kuck KH |title=Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg) |journal=Am. Heart J. |volume=127 |issue=4 Pt 2 |pages=1139–44 |year=1994 |month=April |pmid=8160593 |doi= |url=}}</ref><ref name="pmid11102258">{{cite journal |author=Connolly SJ, Hallstrom AP, Cappato R, ''et al.'' |title=Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study |journal=Eur. Heart J. |volume=21 |issue=24 |pages=2071–8 |year=2000 |month=December |pmid=11102258 |doi=10.1053/euhj.2000.2476 |url=}}</ref>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | |||
|} | |||
==Sources== | ==Sources== | ||
Revision as of 01:57, 28 December 2012
|
ST Elevation Myocardial Infarction Microchapters |
|
Differentiating ST elevation myocardial infarction from other Diseases |
|
Diagnosis |
|
Treatment |
|
|
Case Studies |
|
ST elevation myocardial infarction discharge care On the Web |
|
ST elevation myocardial infarction discharge care in the news |
|
Directions to Hospitals Treating ST elevation myocardial infarction |
|
Risk calculators and risk factors for ST elevation myocardial infarction discharge care |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
2013 Revised ACCF/AHA Guidelines for the Management of ST-Elevation Myocardial Infarction (DO NOT EDIT)[1]
Implantable Cardioverter-Defibrillator Therapy Before Discharge (DO NOT EDIT)[1]
| Class I |
| "1. Implantable cardioverter-defibrillator therapy is indicated before discharge in patients who develop sustained ventricular tachycardia/ventricular fibrillation more than 48 hours after STEMI, provided the arrhythmia is not due to transient or reversible ischemia, reinfarction, or metabolic abnormalities.[2][3][4](Level of Evidence: B)" |
Sources
References
- ↑ 1.0 1.1 O'Gara PT, Kushner FG, Ascheim DD; et al. (2012). "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0b013e3182742c84. PMID 23247303. Unknown parameter
|month=ignored (help) - ↑ Wever EF, Hauer RN, van Capelle FL; et al. (1995). "Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors". Circulation. 91 (8): 2195–203. PMID 7697849. Unknown parameter
|month=ignored (help) - ↑ Siebels J, Kuck KH (1994). "Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg)". Am. Heart J. 127 (4 Pt 2): 1139–44. PMID 8160593. Unknown parameter
|month=ignored (help) - ↑ Connolly SJ, Hallstrom AP, Cappato R; et al. (2000). "Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study". Eur. Heart J. 21 (24): 2071–8. doi:10.1053/euhj.2000.2476. PMID 11102258. Unknown parameter
|month=ignored (help)